• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhibition of androgen aromatization in human breast cancer.

作者信息

Abul-Hajj Y J

出版信息

J Steroid Biochem. 1980 Dec;13(12):1395-400. doi: 10.1016/0022-4731(80)90049-7.

DOI:10.1016/0022-4731(80)90049-7
PMID:7464118
Abstract
摘要

相似文献

1
Inhibition of androgen aromatization in human breast cancer.
J Steroid Biochem. 1980 Dec;13(12):1395-400. doi: 10.1016/0022-4731(80)90049-7.
2
Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Endocrinology. 1984 Jun;114(6):2128-37. doi: 10.1210/endo-114-6-2128.
3
Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.氨鲁米特、睾酮内酯和4-羟基雄烯二酮作为芳香化酶抑制剂的相加作用。
J Steroid Biochem. 1984 Jun;20(6A):1239-42. doi: 10.1016/0022-4731(84)90151-1.
4
Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
Steroids. 1980 May;35(5):533-41. doi: 10.1016/s0039-128x(80)80007-9.
5
Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.芳香化酶抑制剂与人类乳腺肿瘤中雌激素合成的意义的比较研究。
Cancer Res. 1982 Aug;42(8 Suppl):3373s-3377s.
6
Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.芳香化酶抑制剂4-羟基雄烯二酮的作用机制研究。
Steroids. 1983 Jun;41(6):783-90. doi: 10.1016/0039-128x(83)90053-3.
7
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
J Med Chem. 1978 Oct;21(10):1007-11. doi: 10.1021/jm00208a002.
8
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.低剂量氨鲁米特对绝经后乳腺癌患者外周芳香化作用的有效抑制
Br J Cancer. 1985 Jul;52(1):31-5. doi: 10.1038/bjc.1985.144.
9
Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.人乳腺肿瘤中的雌激素合成及其受睾内酯和溴雄烯二酮的抑制作用。
Cancer Res. 1982 Aug;42(8 Suppl):3338s-3341s.
10
Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
Biochemistry. 1976 Oct 19;15(21):4730-6. doi: 10.1021/bi00666a030.

引用本文的文献

1
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer.福美司坦。其治疗绝经后乳腺癌的药理特性及临床疗效综述。
Drugs Aging. 1996 Oct;9(4):292-306. doi: 10.2165/00002512-199609040-00006.
2
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.福美司坦。对其药效学、药代动力学特性以及在乳腺癌和前列腺癌治疗中的潜在应用的综述。
Drugs. 1993 Jan;45(1):66-84. doi: 10.2165/00003495-199345010-00007.
3
Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients.
Breast Cancer Res Treat. 1981;1(3):263-6. doi: 10.1007/BF01806266.
4
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.低剂量氨鲁米特对绝经后乳腺癌患者外周芳香化作用的有效抑制
Br J Cancer. 1985 Jul;52(1):31-5. doi: 10.1038/bjc.1985.144.